About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Fuji Pharma Co.,Ltd.(4554) Summary

4554
TSE Prime
Fuji Pharma Co.,Ltd.
1,256
JPY
+7
(+0.56%)
Apr 9, 3:30 pm JST
8.63
USD
Apr 9, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
9.0
PBR
0.64
Yield
3.62%
Margin Trading Ratio
20.40
Stock Price
Apr 9, 2025
Opening Apr 9, 9:00 am
1,232 JPY 8.44 USD
Previous Close Apr 8
1,249 JPY 8.46 USD
High Apr 9, 9:13 am
1,270 JPY 8.71 USD
Low Apr 9, 9:00 am
1,232 JPY 8.44 USD
Volume
159,900
Trading Value
0.20B JPY 1.38M USD
VWAP
1253.09 JPY 8.62 USD
Minimum Trading Value
125,600 JPY 863 USD
Market Cap
0.03T JPY 0.22B USD
Number of Trades
976
Liquidity & Number of Trades
As of Apr 9, 2025
Liquidity
Mid
1-Year Average
381
1-Year High Jul 19, 2024
2,487
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 11,100 171,000 15.41
Mar 28, 2025 14,500 193,100 13.32
Mar 21, 2025 10,600 215,500 20.33
Mar 14, 2025 10,200 217,500 21.32
Mar 7, 2025 10,300 218,500 21.21
Company Profile
Fuji Pharma Co., Ltd. is a leading generic pharmaceutical company, specializing in fertility treatments and contrast agents. The company is also expanding into new drugs and biosimilars.
Sector
Pharmaceuticals
Fuji Pharma Co., Ltd. is a major generic drug manufacturer, primarily focusing on injectable products such as hormone preparations for obstetrics and gynecology, and urinary tract and vascular contrast agents for radiology. The company operates through five branch offices nationwide, engaging in the development, manufacturing, and sales of pharmaceuticals. With one consolidated subsidiary, Fuji Pharma conducts product trading and financial lending with its Thai subsidiary. Operating under a single pharmaceutical business segment, the company offers a diverse product lineup to meet a wide range of medical needs. As a pharmaceutical manufacturer with particular strengths in obstetrics, gynecology, and radiology, Fuji Pharma Co., Ltd. conducts business both domestically and internationally.